Mankind Pharma Files FY26 BRSR Report

Mankind Pharma Ltd has submitted its Business Responsibility & Sustainability Report (BRSR) for the financial year 2025-26. The report details the company's adherence to nine principles of responsible business conduct, covering integrity, sustainable products, employee well-being, stakeholder interests, human rights, environmental protection, responsible policy engagement, inclusive growth, and consumer value. The filing includes corporate identity, registered and corporate addresses, contact details, stock exchange listings (BSE and NSE), paid-up capital, and the reporting boundary (standalone basis). It also outlines business activities contributing to turnover, including wholesale trading (53.06%) and manufacturing of pharmaceuticals (46.94%). The report specifies operations across 15 national locations and 2 international offices, serving 28 states and 8 union territories nationally and 38 countries internationally, with exports contributing 9.45% to turnover. Employee details as of FY26 show 19,270 total employees, with 18,763 permanent staff.